Haurwitz Rachel E. — SEC Form 4 filings

SEC reporting owner CIK 1670579. 5 Form 4 filings on record with FilingPulse; latest filed 2026-02-20.

Transaction summary — filings shown

Covers all 5 filings on record, filed 2024-02-22 to 2026-02-20. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Caribou Biosciences, Inc. (CRBU)President and CEO, Director41 leg · 20,000 sh · $20,4006
Seer, Inc. (SEER)Director11

Form 4 filings — Haurwitz Rachel E.

FiledFormIssuerReported transactionsSource
2026-02-204Caribou Biosciences, Inc. (CRBU)Grant/award (A): 151,700 @ $0 · Grant/award (A): 682,500 (derivative) @ $0EDGAR
2025-03-174Caribou Biosciences, Inc. (CRBU)Purchase (P): 20,000 @ $1.02EDGAR
2025-02-214Caribou Biosciences, Inc. (CRBU)Grant/award (A): 136,750 @ $0 · Grant/award (A): 618,250 (derivative) @ $0EDGAR
2024-06-144Seer, Inc. (SEER)Grant/award (A): 58,178 @ $0EDGAR
2024-02-224Caribou Biosciences, Inc. (CRBU)Grant/award (A): 118,700 @ $0 · Grant/award (A): 546,950 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1670579 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →